Endocrinology 150:17121722 Kerr BD, Flatt PR, Gault VA (2010) (D-nn2)Oxm[mPEG-PAL]: a novel chemically modified analogue of oxyntomodulin with antihyperglycaemic, insulinotropic and anorexigenic actions
Glucagon-Like Peptide 1 Receptor Agonists (GLP1-RA) and the Clinical Outcomes of Inflammatory Bowel Disease (IBD): A Systematic Review and Meta-analysis
Many laboratories choose it for research environments where practical multi-use handling may be beneficial
2 The new generation of obesity management medications, glucagon-like peptide-1 (GLP-1) receptor agonists liraglutide (Saxenda) and semaglutide (Wegovy), as well as dual GLP-1 and glucose-dependent insulinotropic polypeptide receptor agonist tirzepatide (Zepbound), have demonstrated unprecedented efficacy in weight reduction, averaging 15% to 25% total body weight loss
Limit alcohol consumption , which can worsen dehydration and lightheadedness, and be cautious with activities requiring alertness until symptoms resolve